JP2005524627A5 - - Google Patents

Download PDF

Info

Publication number
JP2005524627A5
JP2005524627A5 JP2003562091A JP2003562091A JP2005524627A5 JP 2005524627 A5 JP2005524627 A5 JP 2005524627A5 JP 2003562091 A JP2003562091 A JP 2003562091A JP 2003562091 A JP2003562091 A JP 2003562091A JP 2005524627 A5 JP2005524627 A5 JP 2005524627A5
Authority
JP
Japan
Prior art keywords
dihydropyrimidine
oxo
methyl
ethynyl
trimethylsilyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003562091A
Other languages
English (en)
Japanese (ja)
Other versions
JP4498745B2 (ja
JP2005524627A (ja
Filing date
Publication date
Priority claimed from GBGB0201179.9A external-priority patent/GB0201179D0/en
Application filed filed Critical
Publication of JP2005524627A publication Critical patent/JP2005524627A/ja
Publication of JP2005524627A5 publication Critical patent/JP2005524627A5/ja
Application granted granted Critical
Publication of JP4498745B2 publication Critical patent/JP4498745B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003562091A 2002-01-18 2003-01-15 ピリミジノンウイルスポリメラーゼ阻害剤 Expired - Fee Related JP4498745B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201179.9A GB0201179D0 (en) 2002-01-18 2002-01-18 Therapeutic agents
PCT/GB2003/000124 WO2003062211A1 (en) 2002-01-18 2003-01-15 Pyrimidinone viral polymerase inhibitors

Publications (3)

Publication Number Publication Date
JP2005524627A JP2005524627A (ja) 2005-08-18
JP2005524627A5 true JP2005524627A5 (https=) 2010-02-04
JP4498745B2 JP4498745B2 (ja) 2010-07-07

Family

ID=9929352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003562091A Expired - Fee Related JP4498745B2 (ja) 2002-01-18 2003-01-15 ピリミジノンウイルスポリメラーゼ阻害剤

Country Status (8)

Country Link
US (1) US20050130997A1 (https=)
EP (1) EP1470113B1 (https=)
JP (1) JP4498745B2 (https=)
AT (1) ATE420078T1 (https=)
CA (1) CA2473508A1 (https=)
DE (1) DE60325692D1 (https=)
GB (1) GB0201179D0 (https=)
WO (1) WO2003062211A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062613A2 (en) 2003-01-13 2004-07-29 Bristol-Myers Squibb Company Hiv integrase inhibitors
US20050075309A1 (en) 2003-07-25 2005-04-07 Richard Storer Purine nucleoside analogues for treating Flaviviridae including hepatitis C
WO2005016384A1 (ja) * 2003-08-13 2005-02-24 Bf Research Institute, Inc. アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤
AR046938A1 (es) * 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
CN102911161A (zh) 2004-02-20 2013-02-06 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
AU2006242475B2 (en) 2005-05-02 2011-07-07 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
TWI387603B (zh) 2005-07-20 2013-03-01 Merck Sharp & Dohme Hcv ns3蛋白酶抑制劑
BRPI0614205A2 (pt) 2005-08-01 2016-11-22 Merck & Co Inc composto, composição farmacêutica, e, uso de composto
US7939537B2 (en) * 2005-10-04 2011-05-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HIV integrase inhibitors
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
US8138164B2 (en) 2006-10-24 2012-03-20 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
JP2010507656A (ja) 2006-10-24 2010-03-11 メルク エンド カムパニー インコーポレーテッド Hcvns3プロテアーゼ阻害剤
CN101583372A (zh) 2006-10-24 2009-11-18 默克公司 Hcv ns3蛋白酶抑制剂
WO2008057209A1 (en) 2006-10-27 2008-05-15 Merck & Co., Inc. Hcv ns3 protease inhibitors
AU2007318164B2 (en) 2006-10-27 2013-02-07 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
CN103224506A (zh) 2006-12-20 2013-07-31 P.安杰莱蒂分子生物学研究所 抗病毒的吲哚
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
EP2142215B1 (en) 2007-05-04 2012-03-07 Vertex Pharmceuticals Incorporated Combination therapy for the treatment of hcv infection
US7763630B2 (en) 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
AU2008277440A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis C infections
AU2008277377B2 (en) 2007-07-19 2013-08-01 Msd Italia S.R.L. Macrocyclic compounds as antiviral agents
CA2693997C (en) * 2007-08-03 2013-01-15 Pierre L. Beaulieu Viral polymerase inhibitors
CN101903351B (zh) 2007-12-19 2014-09-10 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
AU2009241445A1 (en) 2008-04-28 2009-11-05 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
PT2540350E (pt) 2008-07-22 2014-08-27 Merck Sharp & Dohme Combinações de um composto de quinoxalina macrocílico o qual é um inibidor da protease ns3 do hcv com outros agentes do hcv
JP2012514605A (ja) 2009-01-07 2012-06-28 サイネクシス,インコーポレーテッド Hcvおよびhiv感染の治療への使用におけるシクロスポリン誘導体
US8450363B2 (en) 2009-02-06 2013-05-28 Elan Pharmaceuticals, Inc. Inhibitors of Jun N-terminal kinase
US8143244B2 (en) 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
MX2011010047A (es) * 2009-03-25 2011-10-11 Abbott Lab Compuestos antivirales y usos de los mismos.
US8828930B2 (en) 2009-07-30 2014-09-09 Merck Sharp & Dohme Corp. Hepatitis C virus NS3 protease inhibitors
US8383639B2 (en) 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
MX2013001273A (es) 2010-08-13 2013-04-10 Hoffmann La Roche Compuestos heterociclicos antivirales.
US9328075B2 (en) * 2011-05-05 2016-05-03 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for treating influenza

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
DE19817265A1 (de) * 1998-04-18 1999-10-21 Bayer Ag Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
CA2343522A1 (en) * 1998-09-04 2000-03-16 Viropharma Incorporated Methods for treating or preventing viral infections and associated diseases
GB0017676D0 (en) * 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase

Similar Documents

Publication Publication Date Title
JP2005524627A5 (https=)
CN1209336C (zh) 生产2-卤代苯甲酸的方法
CN1582272A (zh) 制备5-(3-氰基苯基)-3-甲酰基苯甲酸化合物的方法
JP2011514871A5 (https=)
JP4377594B2 (ja) β−アルコキシプロピオンアミド類の製造方法
CN114573512B (zh) 一种合成c2-二氟烷基苯并咪唑衍生物的方法
JP2008526897A5 (https=)
CN1239464C (zh) 2-烷基-2-金刚烷基(甲基)丙烯酸酯的制造方法
JP2003212823A5 (https=)
JPH051000A (ja) シクロヘキシル酪酸誘導体及びその製造法
US6498264B2 (en) Silyl (meth)acrylates having bulky substituent group and preparation thereof
CN1314673C (zh) 具有手性的多齿噁唑啉配体及其与主族金属或过渡金属的配合物、合成方法及其用途
JP5129699B2 (ja) メチル=ヘキサデカ−8−イノアートの製造方法
CN1642964A (zh) 铜络合物和利用该铜络合物形成含铜薄膜的方法
CN103249714B (zh) 山椒素类的制造方法
JP2004535444A5 (https=)
JP2003201281A (ja) 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法
EP0371875A2 (en) Process for preparing 4-acetoxyazetidinones
CN115594621B (zh) 一种二硒醚类化合物的球磨机械化学合成方法
CN114181097A (zh) 一种盐酸甲氧明的合成方法
JP3895053B2 (ja) ジハロメチルシラン類の製法
JP2002332289A (ja) 嵩高い置換基を有するシリル(メタ)アクリレート化合物及びその製造方法
CN1173986C (zh) 一种高碳糖的合成方法
CN1179959C (zh) 高碳糖类化合物的中间体、合成方法及其用途
JP7041092B2 (ja) ビアリールホスフィンの製造方法